Markets:

Overview

News

Currencies

International

Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 01, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy

June 10, 2022

From IVERIC bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022 ↗

June 08, 2022

Upgrades

Via Benzinga

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 02, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Present at the UBS Global Healthcare Conference 2022

May 17, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference

May 16, 2022

From IVERIC bio, Inc.

Via Business Wire

IVERIC bio: Q1 Earnings Insights ↗

May 04, 2022

IVERIC bio (NASDAQ:ISEE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IVERIC bio reported in-line EPS of...

Via Benzinga

Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results

May 04, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy

May 04, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 03, 2022

From IVERIC Bio, Inc.

Via Business Wire

IVERIC bio Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 28, 2022

IVERIC bio (NASDAQ:ISEE) will host a conference call at 08:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend IVERIC bio (ISEE) Conference Call Follow this link to access the...

Via Benzinga

Iveric Bio to Report First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 4, 2022

April 27, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Participate in the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference

April 26, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 01, 2022

From Iveric Bio

Via Business Wire

These Are Ten Small Cap Stocks With Strong Buy Recommendations ↗

March 27, 2022

One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022 ↗

March 22, 2022

Upgrades For Procter & Gamble Co (NYSE:PG), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Procter & Gamble had an EPS of $1.66,...

Via Benzinga

Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks ↗

March 09, 2022

Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗

March 03, 2022

Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,...

Via Benzinga

Iveric Bio to Present at the Cowen 42nd Annual Health Care Conference

February 28, 2022

From Iveric Bio

Via Business Wire

Iveric Bio Reports Fourth Quarter and Full Year 2021 Operational Highlights and Financial Results

February 24, 2022

From IVERIC bio, Inc.

Via Business Wire

Earnings Outlook For IVERIC bio ↗

February 23, 2022

IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Iveric Bio to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022

February 17, 2022

From IVERIC bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 11, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI...

Via Benzinga

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO ↗

February 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...

Via Benzinga

Iveric Bio Announces Foveal Anatomy Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy

February 11, 2022

From IVERIC bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 10, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI)...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022 ↗

February 07, 2022

Upgrades For Enova International Inc (NYSE:ENVA), Maxim Group upgraded the previous rating of Hold to Buy. For the fourth quarter, Enova International had an EPS of $1.61,...

Via Benzinga

Futures Tread Water Amid Peripheral Bond Rout As Key CPI Print Looms ↗

February 07, 2022

U.S. index futures swung around in a volatile, illiquid overnight session, and at last check were flat despite traders' concerns about growing fireworks in the European bond market where Italian and...

Via Talk Markets

Iveric Bio Announces New Post-Hoc Analyses of Zimura® from GATHER1 Clinical Trial to Be Presented at Angiogenesis, Exudation, and Degeneration 2022

February 07, 2022

From IVERIC Bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 02, 2022

From IVERIC bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

All News about IVERIC bio, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today